Originally published In Press as doi:10.1074/jbc.M404568200 on June 10, 2004
J. Biol. Chem., Vol. 279, Issue 35, 36287-36292, August 27, 2004
Differential Activation of Smads in HeLa and SiHa Cells That Differ in Their Response to Transforming Growth Factor-
*
Tessy T. Maliekal,
Ruby John Anto, and
Devarajan Karunagaran
From the
Division of Cancer Biology, Rajiv Gandhi Center for Biotechnology, Thiruvananthapuram, Kerala 695 014, India
We assessed the responsiveness of six human cervical cancer cell lines to transforming growth factor (TGF)-
with p3TP-lux reporter assay and found that HeLa and SiHa cells were highly responsive to TGF-
. However, when pSBE4-BV/Luc reporter with four Smad binding elements was used, only the SiHa, not the HeLa, cells showed Smad activation. Smad DNA binding activity was relatively more in SiHa than in HeLa cells upon TGF-
treatment, and the active complex contained Smad 2 and Smad 4. In 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays, HeLa cells treated with 5 ng/ml of TGF-
for 24 h showed proliferation, whereas SiHa cells showed growth inhibition under the same conditions. TGF-
treatment resulted in G0/G1 arrest with a reduction in S-phase only in SiHa cells. A chemical inhibitor of Smad activation (SB203580) blocked the growth inhibitory effect of TGF-
in SiHa, whereas the proliferative response in HeLa was unaffected. TGF-
-induced translocation of phospho-Smad 2 was relatively less in HeLa than in SiHa cells. MAPK activation occurred within 5 min and persisted up to 15 min upon TGF-
treatment in HeLa but was negligible in SiHa cells. TGF-
activated JNK in HeLa, but SiHa cells showed a down-regulation of its activity. When an inhibitor of MAPK (U0126) was used, the TGF-
-mediated proliferative response in HeLa cells was completely abolished. SB203580 did not affect MAPK activation induced by TGF-
in HeLa cells. We report for the first time an activation, presumably independent of Smad activation, of TGF-
-dependent MAPK within 5 min of treatment that resulted in cell cycle progression in a cervical adenocarcinoma cell line, HeLa.
Received for publication, April 26, 2004
, and in revised form, June 10, 2004.
* This work was supported by a research grant from the Department of Science and Technology (to D. K.), by program support to the Rajiv Gandhi Center from the Department of Biotechnology, and by a senior research fellowship (to T. T. M.) from the Council of Scientific and Industrial Research, Government of India. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 91-471-2347975; Fax: 91-471-2348096; E-mail: dkarunagaran{at}hotmail.com.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Ren, P. C. Charles, C. Zhang, Y. Wu, H. Wang, and C. Patterson
Gene expression profiles identify a role for cyclooxygenase 2-dependent prostanoid generation in BMP6-induced angiogenic responses
Blood,
April 1, 2007;
109(7):
2847 - 2853.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Stuhlmeier and C. Pollaschek
Adenovirus-mediated Gene Transfer of Mutated I{kappa}B Kinase and I{kappa}B{alpha} Reveal NF-{kappa}B-dependent as Well as NF-{kappa}B-independent Pathways of HAS1 Activation
J. Biol. Chem.,
December 30, 2005;
280(52):
42766 - 42773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. N. Kloth, G. J. Fleuren, J. Oosting, R. X. de Menezes, P. H.C. Eilers, G. G. Kenter, and A. Gorter
Substantial changes in gene expression of Wnt, MAPK and TNF{alpha} pathways induced by TGF-{beta}1 in cervical cancer cell lines
Carcinogenesis,
September 1, 2005;
26(9):
1493 - 1502.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.